Trials / Completed
CompletedNCT01953497
Phase 1 Study of URC102 in Healthy Subjects
A Phase I, Placebo-controlled, Randomized, Double Blind, Single or Multiple Dose Study of URC102 in Healthy Male Volunteers of Korean and Caucasian to Assess Safety, Pharmacokinetics and Pharmacodynamics
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 81 (actual)
- Sponsor
- JW Pharmaceutical · Industry
- Sex
- Male
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To assess the safety, tolerability, PK and PD of URC102 in healthy subjects. To evaluate the food effect on PK.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | URC102 | |
| DRUG | Placebo |
Timeline
- Start date
- 2013-05-23
- Primary completion
- 2013-12-24
- Completion
- 2014-07-01
- First posted
- 2013-10-01
- Last updated
- 2017-03-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01953497. Inclusion in this directory is not an endorsement.